Adler, Sabine; Sprecher, Marco; Wermelinger, Felix; Klink, Thorsten; Bonel, Harald Marcel; Villiger, Peter M (2017). Diagnostic value of contrast-enhanced magnetic resonance angiography in large-vessel vasculitis. Swiss medical weekly, 147, w14397. EMH Schweizerischer Ärzteverlag 10.4414/smw.2017.14397
|
Text
Diagnostic value of contrast-enhanced magnetic resonance angiography in large-vessel vasculitis.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (418kB) | Preview |
OBJECTIVE
To evaluate contrast-enhanced magnetic resonance angiography (MRA) in diagnosis of inflammatory aortic involvement in patients with clinical suspicion of large-vessel vasculitis.
PATIENTS AND METHODS
Seventy-five patients, mean age 62 years (range 16-82 years), 44 female and 31 male, underwent gadolinium-enhanced MRA and were evaluated retrospectively. Thoracic MRA was performed in 32 patients, abdominal MRA in 7 patients and both thoracic and abdominal MRA in 36 patients. Temporal arterial biopsies were obtained from 22/75 patients. MRA positivity was defined as increased aortic wall signal in late gadolinium-enhanced axial turbo inversion recovery magnitude (TIRM) series. The influence of prior glucocorticoid intake on MRA outcome was evaluated.
RESULTS
MRA was positive in 24/75 patients, with lesions located in the thorax in 7 patients, the abdomen in 5 and in both thorax and abdomen in 12. Probability for positive MRA after glucocorticoid intake for more than 5 days before MRA was reduced by 89.3%. Histology was negative in 3/10 MRA-positive patients and positive in 5/12 MRA-negative patients. All 5/12 histology positive / MRA-negative patients had glucocorticoids for >5 days prior to MRA and were diagnosed as having vasculitis. Positive predictive value for MRA was 92%, negative predictive value was 88%.
CONCLUSIONS
Contrast-enhanced MRA reliably identifies large vessel vasculitis. Vasculitic signals in MRA are very sensitive to glucocorticoids, suggesting that MRA should be done before glucocorticoid treatment.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Rheumatology and Immunology 04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Institute of Diagnostic, Interventional and Paediatric Radiology |
UniBE Contributor: |
Adler, Sabine, Wermelinger, Felix, Bonel, Harald Marcel |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1424-7860 |
Publisher: |
EMH Schweizerischer Ärzteverlag |
Language: |
English |
Submitter: |
Nicole Rösch |
Date Deposited: |
16 Jan 2018 16:00 |
Last Modified: |
05 Dec 2022 15:09 |
Publisher DOI: |
10.4414/smw.2017.14397 |
PubMed ID: |
28322426 |
BORIS DOI: |
10.7892/boris.108387 |
URI: |
https://boris.unibe.ch/id/eprint/108387 |
Actions (login required)
 |
Edit item |